Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Capital Expenditures (2017 - 2025)

Innovex International (INVX) has disclosed Capital Expenditures for 17 consecutive years, with $8.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 17.04% year-over-year to $8.9 million, compared with a TTM value of $35.1 million through Dec 2025, up 158.44%, and an annual FY2025 reading of $35.1 million, up 158.44% over the prior year.
  • Capital Expenditures was $8.9 million for Q4 2025 at Innovex International, down from $11.9 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $11.9 million in Q3 2025 and bottomed at -$4.1 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $4.2 million, with a median of $2.5 million recorded in 2021.
  • The sharpest move saw Capital Expenditures plummeted 300.63% in 2022, then surged 647.4% in 2023.
  • Year by year, Capital Expenditures stood at $2.1 million in 2021, then tumbled by 300.63% to -$4.1 million in 2022, then surged by 127.6% to $1.1 million in 2023, then skyrocketed by 567.86% to $7.6 million in 2024, then grew by 17.04% to $8.9 million in 2025.
  • Business Quant data shows Capital Expenditures for INVX at $8.9 million in Q4 2025, $11.9 million in Q3 2025, and $7.3 million in Q2 2025.